May 11, 2025, 00:46

ASTRO-BCRF Emerging Investigator Award

This joint award by ASTRO and the Breast Cancer Research Foundation (BCRF) aims to foster the career development of early-stage investigators in breast radiation oncology research. Applicants must dedicate at least 20% of their career responsibilities to the research project and associated training plan. The grant is intended to support promising research and structured career development.

Eligibility:

Must be an early-stage investigator (per NIH definition) with a PhD, MD, MD/PhD, or equivalent terminal degree
Minimum of 20% effort committed to the project
Must be affiliated with a U.S.-based nonprofit or academic research institution
Residents, postdocs, or other trainees are generally not eligible

Funding:

Up to USD 100,000 for one year
No indirect costs covered
Up to 20% of the budget should support the applicant’s career development or training
One no-cost extension may be granted (total period cannot exceed two years)

Deadline:

Extended deadline: June 1, 2025, 11:59 p.m. Eastern Time
Earliest start date: January 1, 2026

More Information:

Application Portal – ProposalCentral

For questions: [email protected]

ASTRO BCRF Breast Cancer cancer cancer grant career development early-career scientists emerging investigator award OncoDaily Oncology oncology research radiation oncology Training Award

FDA Grants Accelerated Approval for Telisotuzumab Vedotin (EMRELIS™) in c-MET–Overexpressing Advanced Non-Small Cell Lung Cancer

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research

In Memory of Bob Marley: His Battle with Melanoma and the Importance of Early Detection

Who From Oncology is Featured in TIME100 Health 2025?

FDA Announces Aggressive Timeline to Scale 1st AI-Assisted Scientific Review Pilot